PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Cold Spring Harbor Laboratory press announces the release of the medical revolution of messenger RNA by Fabrice Delaye

Includes the story behind the 2023 Nobel Prize in Physiology or Medicine

Cold Spring Harbor Laboratory press announces the release of the medical revolution of messenger RNA by Fabrice Delaye
2023-10-17
(Press-News.org)

Cold Spring Harbor, NY - Cold Spring Harbor Laboratory Press (CSHL Press), a publisher of scientific books, journals, and electronic media, today announced the publication of The Medical Revolution of Messenger RNA by science and technology journalist Fabrice Delaye.

Many people think it took just ten months to develop a vaccine against the virus that causes COVID-19. What most don’t know is that it was made possible by using messenger RNA (mRNA), the molecule that instructs cells to make a viral protein that stimulates the production of antiviral antibodies, and that this breakthrough technology, which Nobel Prize winner Thomas Cech calls biology’s equivalent of putting a man on the moon, had been in development for three frustrating decades—decades preceded by thirty years of fundamental research. In fact, two scientists, Katalin Karikó and Drew Weissman, won the 2023 Nobel Prize in Physiology or Medicine for their pioneering work in messenger RNA.

Karikó and Weissman are among the many prominent scientists interviewed by veteran science journalist Fabrice Delaye for his book The Medical Revolution of Messenger RNA, which tells the story of how mRNA’s medical potential was finally realized, setting the stage for a coming revolution in which our own bodies will generate the therapeutic molecules we need. Though it’s now thought to show promise for the treatment of everything from cancer to cystic fibrosis to cardiovascular disease, mRNA was long overlooked by mainstream molecular biologists. The path to recognition of its therapeutic possibilities was littered with broken careers, lawsuits, and opportunities missed by pharmaceutical companies. For the scientists who persisted through years of academic and commercial disappointment, the COVID-19 vaccine was a huge vindication and an important step toward a new generation of therapies.

When mRNA-based vaccines came to the rescue during the pandemic in seemingly record time, Delaye realized that their development could not have been as simple and quick as people wanted to believe. But when he tracked down the origins of mRNA technologies, he uncovered a dramatic story that had never been told. Building on decades of contacts and his unique grasp of the science and the stakes involved, Delaye interviewed more than fifty mRNA scientists and entrepreneurs worldwide. His book documents the long, harrowing, unlikely but ultimately triumphant road to a discovery with the potential to revolutionize medicine far beyond the pandemic.

For more information visit https://cshlpress.com/link/messengerrna.htm.

Fabrice Delaye is a science and technology journalist based in Switzerland. He was U.S. correspondent at the daily Swiss newspaper L’Agefi, science and technology editor at magazine Bilan, and is now a reporter-at-large for Heidi.news in Geneva. He is a graduate of the Institut d'Études Politiques de Paris and has a master’s degree from the Swiss Institute of Technology in Lausanne, EPFL.

About Cold Spring Harbor Laboratory Press

Cold Spring Harbor Laboratory Press is an internationally renowned not-for-profit publisher of books, journals, and electronic media, located on Long Island, New York. Since 1933, it has furthered the advance and spread of scientific knowledge in all areas of genetics and molecular biology, including cancer biology, plant science, bioinformatics, and neurobiology. It is a division of Cold Spring Harbor Laboratory, an innovator in life science research and the education of scientists, students, and the public. All revenue from sales of CSHL Press publications supports research at Cold Spring Harbor Laboratory.

END


[Attachments] See images for this press release:
Cold Spring Harbor Laboratory press announces the release of the medical revolution of messenger RNA by Fabrice Delaye Cold Spring Harbor Laboratory press announces the release of the medical revolution of messenger RNA by Fabrice Delaye 2 Cold Spring Harbor Laboratory press announces the release of the medical revolution of messenger RNA by Fabrice Delaye 3

ELSE PRESS RELEASES FROM THIS DATE:

Largest US cardiac database shows excellent long-term survival after surgical aortic valve replacement

2023-10-17
A study published today in The Annals of Thoracic Surgery demonstrates outstanding long-term survival following low-risk isolated surgical aortic valve replacement (SAVR). The study reviewed 42,586 patients who underwent low-risk isolated SAVR between 2011 and 2019 at 981 different cardiac surgery programs across the U.S. Conducted by eight leading national investigators, the assessment relied on evidence from The Society of Thoracic Surgeons (STS) National Database, with linkage to the Centers for Disease Control and Prevention’s National Death Index (NDI). The STS ...

Tirzepatide trial shows additional 21.1% weight loss following intensive lifestyle intervention

Tirzepatide trial shows additional 21.1% weight loss following intensive lifestyle intervention
2023-10-17
A phase 3 clinical trial evaluating the injectable prescription medication tirzepatide, showed an additional 21.1% weight loss after intensive lifestyle intervention in adults with obesity or who were overweight with weight-related comorbidities, excluding Type 2 diabetes. The findings of the SURMOUNT-3 study, sponsored by pharmaceutical company Eli Lilly, were simultaneously published this week in the journal Nature Medicine and presented at a national conference of obesity researchers. Tirzepatide, marketed ...

DOE’s Office of Science is now accepting applications for summer 2024 undergraduate internships

2023-10-17
WASHINGTON, DC – Applications are currently being accepted for the Summer 2024 term of two undergraduate internship programs offered by the Department of Energy (DOE) Office of Science: the Science Undergraduate Laboratory Internships (SULI) program and the Community College Internships (CCI) program. The application deadline is January 9, 2024, at 5:00 p.m. EST. Through SULI and CCI, undergraduate students and recent graduates discover science and technology careers at the DOE national laboratories and gain the experience needed to transition ...

DOE’s Office of Science is now accepting applications for summer 2024 visiting faculty program

2023-10-17
WASHINGTON, DC – Applications are currently being accepted for the Summer 2024 term of the DOE Office of Science’s Visiting Faculty Program (VFP). The application deadline is January 9, 2024, at 5:00 p.m. ET. Two application assistance workshops will be held for all faculty interested in applying to VFP: November 17, 2023, at 12:00 p.m. ET (register here) December 1, 2023, at 12:00 p.m. ET (register here) In addition, prospective VFP applicants can engage with recruiters and scientists from the DOE national laboratories at a summer internship fair sponsored by the Office of Workforce ...

Q&A: Researchers aim to improve accessibility with augmented reality

Q&A: Researchers aim to improve accessibility with augmented reality
2023-10-17
Big Tech’s race into augmented reality (AR) grows more competitive by the day. This month, Meta released the latest iteration of its headset, the Quest 3. Early next year, Apple plans to drop its first headset, the Vision Pro. The announcements for each platform emphasize games and entertainment that merge the virtual and physical worlds: a digital board game imposed on a coffee table, a movie screen projected above airplane seats. Some researchers, though, are more curious about other uses for AR. The University of Washington’s Makeability Lab is applying these budding technologies to assist people with disabilities. This month, ...

SEC Insider Trading Rule Has Loopholes

2023-10-17
AUSTIN, Texas -- A rule to limit trading based on nonpublic stock information has limited effectiveness, according to a recent study by Texas McCombs Finance Professor Robert Parrino. Issued in 2000 by the Securities & Exchange Commission, Rule 10b5–1 requires corporate insiders to schedule the purchase or sale of a predetermined number of shares through a third-party broker up to two years in advance. Because the trades under these “plan” sales are scheduled in advance of their execution, insiders are presumed less likely to be acting on inside information. But ...

Smart brain-wave cap recognizes stroke before the patient reaches the hospital

Smart brain-wave cap recognizes stroke before the patient reaches the hospital
2023-10-17
A special brain-wave cap can diagnose stroke in the ambulance, allowing the patient to receive appropriate treatment faster. Jonathan Coutinho, neurologist at Amsterdam UMC, is one of the inventors the swimming cap: "Our research shows that the brain-wave cap can recognize patients with large ischemic stroke with great accuracy. This is very good news, because the cap can ultimately save lives by routing these patients directly to the right hospital." The research is published today in Neurology.  Every year, millions of people worldwide suffer an ischemic stroke, the most common type of stroke. An ischemic stroke occurs ...

Researchers receive $423,500 for study to improve outcomes from fungal infections

Researchers receive $423,500 for study to improve outcomes from fungal infections
2023-10-17
Aspergillus fumigatus is the major airborne fungus present indoors and outdoors that causes various diseases, the severity of which are dependent on an individual’s immune status.  Researchers in the College of Pharmacy at the University of Tennessee Health Science Center have received a $423,500 grant from the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health for research aimed at reducing disease and mortality rates associated with Aspergillus infections ...

Air pollution and breast cancer risk - a link that calls for political action

2023-10-17
Lugano, Switzerland, 17 October 2023 – Women living and working in places with higher levels of fine particle air pollution are more likely to get breast cancer than those living and working in less polluted areas. Results of the first study to take account of the effects of both residential and workplace exposure to air pollution on breast cancer risk are presented at the ESMO Congress 2023 in Madrid, Spain (1).   “Our data showed a statistically significant association between long term exposure to fine particle air pollution, at home and at work, and risk of breast cancer. This contrasts with previous research which looked only at fine particle exposure ...

Thermosensation is critical for the survival of animals, but the mechanisms by which this is modulated by nutritional status remain unclear

Thermosensation is critical for the survival of animals, but the mechanisms by which this is modulated by nutritional status remain unclear
2023-10-17
Thermosensation is critical for the survival of animals, but the mechanisms by which this is modulated by nutritional status remain unclear; here, behavioral and live brain imaging studies reveal why food-sated fruit flies prefer to stay at relatively higher temperatures compared to hungry flies. ##### In your coverage, please use this URL to provide access to the freely available paper in PLOS Biology: http://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.3002332 Article Title: Independent insulin signaling modulators govern hot avoidance ...

LAST 30 PRESS RELEASES:

New register opens to crown Champion Trees across the U.S.

A unified approach to health data exchange

New superconductor with hallmark of unconventional superconductivity discovered

Global HIV study finds that cardiovascular risk models underestimate for key populations

New study offers insights into how populations conform or go against the crowd

Development of a high-performance AI device utilizing ion-controlled spin wave interference in magnetic materials

WashU researchers map individual brain dynamics

Technology for oxidizing atmospheric methane won’t help the climate

US Department of Energy announces Early Career Research Program for FY 2025

PECASE winners: 3 UVA engineering professors receive presidential early career awards

‘Turn on the lights’: DAVD display helps navy divers navigate undersea conditions

MSU researcher’s breakthrough model sheds light on solar storms and space weather

Nebraska psychology professor recognized with Presidential Early Career Award

New data shows how ‘rage giving’ boosted immigrant-serving nonprofits during the first Trump Administration

Unique characteristics of a rare liver cancer identified as clinical trial of new treatment begins

From lab to field: CABBI pipeline delivers oil-rich sorghum

Stem cell therapy jumpstarts brain recovery after stroke

Polymer editing can upcycle waste into higher-performance plastics

Research on past hurricanes aims to reduce future risk

UT Health San Antonio, UTSA researchers receive prestigious 2025 Hill Prizes for medicine and technology

Panorama of our nearest galactic neighbor unveils hundreds of millions of stars

A chain reaction: HIV vaccines can lead to antibodies against antibodies

Bacteria in polymers form cables that grow into living gels

Rotavirus protein NSP4 manipulates gastrointestinal disease severity

‘Ding-dong:’ A study finds specific neurons with an immune doorbell

A major advance in biology combines DNA and RNA and could revolutionize cancer treatments

Neutrophil elastase as a predictor of delivery in pregnant women with preterm labor

NIH to lead implementation of National Plan to End Parkinson’s Act

Growth of private equity and hospital consolidation in primary care and price implications

Online advertising of compounded glucagon-like peptide-1 receptor agonists

[Press-News.org] Cold Spring Harbor Laboratory press announces the release of the medical revolution of messenger RNA by Fabrice Delaye
Includes the story behind the 2023 Nobel Prize in Physiology or Medicine